Rights and permissions
About this article
Cite this article
Alemtuzumab: high antitumour activity in PTL but toxicity “unacceptably high”. Inpharma Wkly. 1439, 18 (2004). https://doi.org/10.2165/00128413-200414390-00046
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414390-00046